

3501. Bioorg Med Chem Lett. 1998 Apr 21;8(8):965-70.

Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of
the quinoline class.

von Sprecher A(1), Gerspacher M, Beck A, Kimmel S, Wiestner H, Anderson GP,
Niederhauser U, Subramanian N, Bray MA.

Author information: 
(1)Research Department, Novartis Pharma AG, Basel, Switzerland.
andreas.von_sprecher@pharma.novartis.com

The two geminal ethyl groups in the succinic acid moiety of CGP57698
(4-[3-(7-fluoro-2-quinolinyl-methoxy)phenyl-amino]-2,2-diethyl-4-oxo- butanoic
acid) are responsible for the high in vitro and in vivo potency of this
peptidoleukotriene antagonist of the quinoline type. The synthesis and structure 
activity relationships of CGP57698 and its analogs are described.

DOI: 10.1016/s0960-894x(98)00137-1 
PMID: 9871521  [Indexed for MEDLINE]

